Skip to main content

TRIGLAV INVESTMENTS, D.O.O.

Position in NBIX — Neurocrine Biosciences Inc

CIK 2056690 LJUBLJANA, 2A

Position in NBIX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,516,860
+$331,200 QoQ
Shares Held
9,000
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#347
of 768 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TRIGLAV INVESTMENTS, D.O.O. holds $3,803,621 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (39.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
9,000 $1,516,860

All Filings in NBIX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,516,860 9,000
2026-03-31 $1,185,660 9,000
2025-12-31 $1,418,300 10,000
2025-09-30 $1,544,180 11,000
2025-06-30 $1,382,590 11,000
2025-03-31 $1,216,600 11,000
2024-12-31 $1,501,500 11,000